|
|
||||||||
The Journal of Immunology, Vol 154, Issue 11 5851-5861, Copyright © 1995 by American Association of Immunologists
ARTICLES |
P Szabolcs, MA Moore and JW Young
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York, NY 10021, USA.
Human CD34+ bone marrow progenitors cultured in the presence of granulocyte-macrophage CSF (GM-CSF) develop along a myeloid pathway, and the addition of exogenous TNF-alpha leads to the differentiation of dendritic cells among the myeloid progeny. These bone marrow CD34+ - derived dendritic cell that develop during 2-wk culture have the same morphologic, phenotypic, and functional properties that distinguish mature dendritic cells in blood. c-kit ligand does not directly influence dendritic cell differentiation per se, but rather increases the total cell number in synergistic combination with GM-CSF and TNF- alpha. This degree of expansion translates into an effective yield of approximately 1.7 x 10(6) mature dendritic cells per single ml of normal adult human bone marrow, compared with approximately 10(6) dendritic cells usually obtained from 450 to 500 ml of peripheral blood. In addition to dendritic cells that constitute approximately 10 to 15% of the total myeloid progeny, the cultures contain monocytes/macrophages and intermediate granulocytic precursors. Monocytes/macrophages and dendritic cells together comprise all of the class II MHC-positive progeny. Sorted cells bearing the CD14+ HLA-DR+ phenotype of mature monocytes are at least 1.5 to 2 logs less active than CD14- HLA-DR+ dendritic cells as stimulators in the allogeneic MLR, even though both CD14+ and CD14- subpopulations share expression of several costimulatory ligands. The synergistic combination of c-kit ligand, GM-CSF, and TNF-alpha therefore expands substantial numbers of immunostimulatory CD14- HLA-DR+ dendritic cells from defined CD34+ progenitors in human bone marrow. This should facilitate the use of dendritic cells in the manipulation of T cell-mediated immune responses.
This article has been cited by other articles:
![]() |
S. J. Elvin, G. D. Healey, A. Westwood, S. C. Knight, J. E. Eyles, and E. D. Williamson Protection against Heterologous Burkholderia pseudomallei Strains by Dendritic Cell Immunization Infect. Immun., March 1, 2006; 74(3): 1706 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. I. Slukvin, M. A. Vodyanik, J. A. Thomson, M. E. Gumenyuk, and K.-D. Choi Directed Differentiation of Human Embryonic Stem Cells into Functional Dendritic Cells through the Myeloid Pathway. J. Immunol., March 1, 2006; 176(5): 2924 - 2932. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yuan, J.-B. Latouche, J. Hodges, A. N. Houghton, G. Heller, M. Sadelain, I. Riviere, and J. W. Young Langerhans-Type Dendritic Cells Genetically Modified to Express Full-Length Antigen Optimally Stimulate CTLs in a CD4-Dependent Manner J. Immunol., February 15, 2006; 176(4): 2357 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O'Mahony, S. Kummar, and M. E. Gutierrez Non-Small-Cell Lung Cancer Vaccine Therapy: A Concise Review J. Clin. Oncol., December 10, 2005; 23(35): 9022 - 9028. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Healey, S. J. Elvin, M. Morton, and E. D. Williamson Humoral and Cell-Mediated Adaptive Immune Responses Are Required for Protection against Burkholderia pseudomallei Challenge and Bacterial Clearance Postinfection Infect. Immun., September 1, 2005; 73(9): 5945 - 5951. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rossi and J. W. Young Human Dendritic Cells: Potent Antigen-Presenting Cells at the Crossroads of Innate and Adaptive Immunity J. Immunol., August 1, 2005; 175(3): 1373 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chang-Rodriguez, W. Hoetzenecker, C. Schwarzler, T. Biedermann, S. Saeland, and A. Elbe-Burger Fetal and neonatal murine skin harbors Langerhans cell precursors J. Leukoc. Biol., March 1, 2005; 77(3): 352 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yuan, J.-B. Latouche, J. L. Reagan, G. Heller, I. Riviere, M. Sadelain, and J. W. Young Langerhans Cells Derived from Genetically Modified Human CD34+ Hemopoietic Progenitors Are More Potent Than Peptide-Pulsed Langerhans Cells for Inducing Antigen-Specific CD8+ Cytolytic T Lymphocyte Responses J. Immunol., January 15, 2005; 174(2): 758 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Avigan Dendritic Cell-Tumor Fusion Vaccines for Renal Cell Carcinoma Clin. Cancer Res., September 15, 2004; 10(18): 6347S - 6352S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ebihara, S. Endo, K. Ito, Y. Ito, K. Akiyama, M. Obinata, and T. Takai Immortalized Dendritic Cell Line with Efficient Cross-Priming Ability Established from Transgenic Mice Harboring the Temperature-Sensitive SV40 Large T-Antigen Gene J. Biochem., September 1, 2004; 136(3): 321 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Encabo, P. Solves, E. Mateu, P. Sepulveda, F. Carbonell-Uberos, and M. D. Minana Selective Generation of Different Dendritic Cell Precursors from CD34+ Cells by Interleukin-6 and Interleukin-3 Stem Cells, September 1, 2004; 22(5): 725 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. O'Neill, H. L. Wilson, B. Quah, J. L. Abbey, G. Despars, and K. Ni Dendritic Cell Development in Long-Term Spleen Stromal Cultures Stem Cells, July 1, 2004; 22(4): 475 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Quah, K. Ni, and H. C. O'Neill In vitro hematopoiesis produces a distinct class of immature dendritic cells from spleen progenitors with limited T cell stimulation capacity Int. Immunol., April 1, 2004; 16(4): 567 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moldenhauer, M. Nociari, G. Lam, A. Salama, S. Rafii, and M. A.S. Moore Tumor Necrosis Factor Alpha-Stimulated Endothelium: An Inducer of Dendritic Cell Development from Hematopoietic Progenitors and Myeloid Leukemic Cells Stem Cells, March 1, 2004; 22(2): 144 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Szabolcs, K.-D. Park, M. Reese, L. Marti, G. Broadwater, and J. Kurtzberg Absolute Values of Dendritic Cell Subsets in Bone Marrow, Cord Blood, and Peripheral Blood Enumerated by a Novel Method Stem Cells, May 1, 2003; 21(3): 296 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Abe, F. O. Yarovinsky, T. Murakami, A. N. Shakhov, A. V. Tumanov, D. Ito, L. N. Drutskaya, K. Pfeffer, D. V. Kuprash, K. L. Komschlies, et al. Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo Blood, February 15, 2003; 101(4): 1477 - 1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ratzinger, J. L. Reagan, G. Heller, K. J. Busam, and J. W. Young Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation Blood, February 15, 2003; 101(4): 1422 - 1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Beaulieu, D. F. Robbiani, X. Du, E. Rodrigues, R. Ignatius, Y. Wei, P. Ponath, J. W. Young, M. Pope, R. M. Steinman, et al. Expression of a Functional Eotaxin (CC Chemokine Ligand 11) Receptor CCR3 by Human Dendritic Cells J. Immunol., September 15, 2002; 169(6): 2925 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Auffermann-Gretzinger, I. S. Lossos, T. A. Vayntrub, W. Leong, F. C. Grumet, K. G. Blume, K. E. Stockerl-Goldstein, R. Levy, and J. A. Shizuru Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients Blood, February 15, 2002; 99(4): 1442 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Stober, R. Schirmbeck, and J. Reimann IL-12/IL-18-Dependent IFN-{{gamma}} Release by Murine Dendritic Cells J. Immunol., July 15, 2001; 167(2): 957 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bauer, V. Redecke, J. W. Ellwart, B. Scherer, J.-P. Kremer, H. Wagner, and G. B. Lipford Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c-, CD123+ Dendritic Cells J. Immunol., April 15, 2001; 166(8): 5000 - 5007. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, H. Kawasaki, H. Nagayama, M. Enomoto, C. Morimoto, K. Tadokoro, T. Juji, and T. A. Takahashi Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages Int. Immunol., February 1, 2001; 13(2): 167 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Curti, M. Fogli, M. Ratta, S. Tura, and R. M. Lemoli Stem Cell Factor and FLT3-Ligand Are Strictly Required to Sustain the Long-Term Expansion of Primitive CD34+DR- Dendritic Cell Precursors J. Immunol., January 15, 2001; 166(2): 848 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Canque, S. Camus, A. Dalloul, E. Kahn, M. Yagello, C. Dezutter-Dambuyant, D. Schmitt, C. Schmitt, and J. C. Gluckman Characterization of dendritic cell differentiation pathways from cord blood CD34+CD7+CD45RA+ hematopoietic progenitor cells Blood, December 1, 2000; 96(12): 3748 - 3756. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Meyer zum Buschenfelde, N. Nicklisch, S. Rose-John, C. Peschel, and H. Bernhard Generation of Tumor-Reactive CTL Against the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells Derived from CD34+ Hemopoietic Progenitor Cells J. Immunol., October 1, 2000; 165(7): 4133 - 4140. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Riedl, J. Stockl, O. Majdic, C. Scheinecker, K. Rappersberger, W. Knapp, and H. Strobl Functional Involvement of E-Cadherin in TGF-{beta}1-Induced Cell Cluster Formation of In Vitro Developing Human Langerhans-Type Dendritic Cells J. Immunol., August 1, 2000; 165(3): 1381 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arpinati, C. L. Green, S. Heimfeld, J. E. Heuser, and C. Anasetti Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells Blood, April 15, 2000; 95(8): 2484 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Spitler, M. L. Grossbard, M. S. Ernstoff, G. Silver, M. Jacobs, F. A. Hayes, and S. J. Soong Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating Factor J. Clin. Oncol., April 1, 2000; 18(8): 1614 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gatti, M. A. Velleca, B. C. Biedermann, W. Ma, J. Unternaehrer, M. W. Ebersold, R. Medzhitov, J. S. Pober, and I. Mellman Large-Scale Culture and Selective Maturation of Human Langerhans Cells from Granulocyte Colony-Stimulating Factor-Mobilized CD34+ Progenitors J. Immunol., April 1, 2000; 164(7): 3600 - 3607. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, H. Kawasaki, H. Nagayama, M. Enomoto, C. Morimoto, K. Tadokoro, T. Juji, and T. A. Takahashi TGF-{beta}1 Reciprocally Controls Chemotaxis of Human Peripheral Blood Monocyte-Derived Dendritic Cells Via Chemokine Receptors J. Immunol., March 1, 2000; 164(5): 2285 - 2295. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ferrero, K. Vettoretto, A. Bondanza, A. Villa, M. Resnati, A. Poggi, and M. R. Zocchi uPA/uPAR System Is Active in Immature Dendritic Cells Derived from CD14+CD34+ Precursors and Is Down-Regulated upon Maturation J. Immunol., January 15, 2000; 164(2): 712 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosenzwajg, L. Tailleux, and J. C. Gluckman CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34+ cells Blood, January 15, 2000; 95(2): 453 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Feng, M. Inaba, Z. Lian, Y. Cui, J. Toki, T. Ito, T. Jin, T. Fan, G. Yang, C. Yu, et al. Development of Mouse Dendritic Cells from Lineage-Negative c-kit‹low Pluripotent Hemopoietic Stem Cells In Vitro Stem Cells, January 1, 2000; 18(1): 53 - 60. [Abstract] [Full Text] |
||||
![]() |
M. Brenner, C. Rossig, U. Sili, J. W. Young, and E. Goulmy Transfusion Medicine: New Clinical Applications of Cellular Immunotherapy Hematology, January 1, 2000; 2000(1): 356 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jaksits, E. Kriehuber, A. S. Charbonnier, K. Rappersberger, G. Stingl, and D. Maurer CD34+ Cell-Derived CD14+ Precursor Cells Develop into Langerhans Cells in a TGF-{beta}1-Dependent Manner J. Immunol., November 1, 1999; 163(9): 4869 - 4877. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Avigan, Z. Wu, J. Gong, R. Joyce, J. Levine, A. Elias, P. Richardson, J. Milano, L. Kennedy, K. Anderson, et al. Selective in Vivo Mobilization with Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)/Granulocyte-CSF ascompared to G-CSF Alone of Dendritic Cell Progenitors from Peripheral Blood Progenitor Cells in Patients with Advanced Breast Cancer Undergoing Autologous Transplantation Clin. Cancer Res., October 1, 1999; 5(10): 2735 - 2741. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cignetti, E. Bryant, B. Allione, A. Vitale, R. Foa, and M.A. Cheever CD34+ Acute Myeloid and Lymphoid Leukemic Blasts Can Be Induced to Differentiate Into Dendritic Cells Blood, September 15, 1999; 94(6): 2048 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Koski, G. N. Schwartz, D. E. Weng, R. E. Gress, F. H.C. Engels, M. Tsokos, B. J. Czerniecki, and P. A. Cohen Calcium Ionophore-Treated Myeloid Cells Acquire Many Dendritic Cell Characteristics Independent of Prior Differentiation State, Transformation Status, or Sensitivity to Biologic Agents Blood, August 15, 1999; 94(4): 1359 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Borges, R. E. Miller, J. Jones, K. Ariail, J. Whitmore, W. Fanslow, and D. H. Lynch Synergistic Action of fms-Like Tyrosine Kinase 3 Ligand and CD40 Ligand in the Induction of Dendritic Cells and Generation of Antitumor Immunity In Vivo J. Immunol., August 1, 1999; 163(3): 1289 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Koski, G. N. Schwartz, D. E. Weng, B. J. Czerniecki, C. Carter, R. E. Gress, and P. A. Cohen Calcium Mobilization in Human Myeloid Cells Results in Acquisition of Individual Dendritic Cell-Like Characteristics Through Discrete Signaling Pathways J. Immunol., July 1, 1999; 163(1): 82 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Arrighi, C. Hauser, B. Chapuis, R. H. Zubler, and V. Kindler Long-Term Culture of Human CD34+ Progenitors With FLT3-Ligand, Thrombopoietin, and Stem Cell Factor Induces Extensive Amplification of a CD34-CD14- and a CD34-CD14+ Dendritic Cell Precursor Blood, April 1, 1999; 93(7): 2244 - 2252. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. St. Louis, J. B. Woodcock, G. Fransozo, P. J. Blair, L. M. Carlson, M. Murillo, M. R. Wells, A. J. Williams, D. S. Smoot, S. Kaushal, et al. Evidence for Distinct Intracellular Signaling Pathways in CD34+ Progenitor to Dendritic Cell Differentiation from a Human Cell Line Model J. Immunol., March 15, 1999; 162(6): 3237 - 3248. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Raje, J. Gong, D. Chauhan, G. Teoh, D. Avigan, Z. Wu, D. Chen, S. P. Treon, I. J. Webb, D. W. Kufe, et al. Bone Marrow and Peripheral Blood Dendritic Cells From Patients With Multiple Myeloma Are Phenotypically and Functionally Normal Despite the Detection of Kaposi's Sarcoma Herpesvirus Gene Sequences Blood, March 1, 1999; 93(5): 1487 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, H. Kawasaki, H. Nagayama, R. Serizawa, J. Ikeda, C. Morimoto, K. Yasunaga, N. Yamaji, K. Tadokoro, T. Juji, et al. CC Chemokine Receptors, CCR-1 and CCR-3, Are Potentially Involved in Antigen-Presenting Cell Function of Human Peripheral Blood Monocyte-Derived Dendritic Cells Blood, January 1, 1999; 93(1): 34 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Armitage Emerging Applications of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Blood, December 15, 1998; 92(12): 4491 - 4508. [Full Text] [PDF] |
||||
![]() |
B. Dubois, C. Massacrier, B. Vanbervliet, J. Fayette, F. Briere, J. Banchereau, and C. Caux Critical Role of IL-12 in Dendritic Cell-Induced Differentiation of Naive B Lymphocytes J. Immunol., September 1, 1998; 161(5): 2223 - 2231. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Guillaume, D. B. Rubinstein, and M. Symann Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation Blood, September 1, 1998; 92(5): 1471 - 1490. [Full Text] [PDF] |
||||
![]() |
A. Varas, A. Vicente, R. Sacedon, and A. G. Zapata Interleukin-7 Influences the Development of Thymic Dendritic Cells Blood, July 1, 1998; 92(1): 93 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Ryncarz and C. Anasetti Expression of CD86 on Human Marrow CD34+ Cells Identifies Immunocompetent Committed Precursors of Macrophages and Dendritic Cells Blood, May 15, 1998; 91(10): 3892 - 3900. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Davis, A. A. Saini, P. J. Blair, B. L. Levine, N. Craighead, D. M. Harlan, C. H. June, and K. P. Lee Phorbol Esters Induce Differentiation of Human CD34+ Hemopoietic Progenitors to Dendritic Cells: Evidence for Protein Kinase C-Mediated Signaling J. Immunol., April 15, 1998; 160(8): 3689 - 3697. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Frey, N. R. Hackett, J. M. Bergelson, R. Finberg, R. G. Crystal, M. A.S. Moore, and S. Rafii High-Efficiency Gene Transfer Into Ex Vivo Expanded Human Hematopoietic Progenitors and Precursor Cells by Adenovirus Vectors Blood, April 15, 1998; 91(8): 2781 - 2792. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ferrero, A. Bondanza, B. E. Leone, S. Manici, A. Poggi, and M. R. Zocchi CD14+CD34+ Peripheral Blood Mononuclear Cells Migrate Across Endothelium and Give Rise to Immunostimulatory Dendritic Cells J. Immunol., March 15, 1998; 160(6): 2675 - 2683. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tarte, S. J. Olsen, Z. Yang Lu, E. Legouffe, J.-F. Rossi, Y. Chang, and B. Klein Clinical-Grade Functional Dendritic Cells From Patients With Multiple Myeloma Are Not Infected With Kaposi's Sarcoma-Associated Herpesvirus Blood, March 15, 1998; 91(6): 1852 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Lyman and S. E. W. Jacobsen c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities Blood, February 15, 1998; 91(4): 1101 - 1134. [Full Text] [PDF] |
||||
![]() |
P. Rovere, V. S. Zimmermann, F. Forquet, D. Demandolx, J. Trucy, P. Ricciardi-Castagnoli, and J. Davoust Dendritic cell maturation and antigen presentation in the absence of invariant chain PNAS, February 3, 1998; 95(3): 1067 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tuting, C. C. Wilson, D. M. Martin, Y. L. Kasamon, J. Rowles, D. I. Ma, C. L. Slingluff Jr., S. N. Wagner, P. van der Bruggen, J. Baar, et al. Autologous Human Monocyte-Derived Dendritic Cells Genetically Modified to Express Melanoma Antigens Elicit Primary Cytotoxic T Cell Responses In Vitro: Enhancement by Cotransfection of Genes Encoding the Th1-Biasing Cytokines IL-12 and IFN-{alpha} J. Immunol., February 1, 1998; 160(3): 1139 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, N. Mukaida, J.-b. Wang, A. Harada, M. Akiyama, and K. Matsushima Induction of Dendritic Cell Differentiation by Granulocyte-Macrophage Colony-Stimulating Factor, Stem Cell Factor, and Tumor Necrosis Factor alpha In Vitro From Lineage Phenotypes-Negative c-kit+ Murine Hematopoietic Progenitor Cells Blood, December 15, 1997; 90(12): 4842 - 4853. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N.J. Hart Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response Blood, November 1, 1997; 90(9): 3245 - 3287. [Full Text] [PDF] |
||||
![]() |
K. Tarte, Z. Y. Lu, G. Fiol, E. Legouffe, J.-F. Rossi, and B. Klein Generation of Virtually Pure and Potentially Proliferating Dendritic Cells From Non-CD34 Apheresis Cells From Patients With Multiple Myeloma Blood, November 1, 1997; 90(9): 3482 - 3495. |